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Bile acids delay aging in yeast via two different 
mechanisms 
 
We recently found that LCA greatly (and some other 
bile acids to a lesser degree) increases the chronological 
life span of yeast under caloric restriction (CR) 
conditions [1]. Our findings provided evidence that 
LCA extends longevity of chronologically aging yeast 
through two different mechanisms (Figure 1).  
 
  In one mechanism, this bile acid targets longevity 
pathways that control chronological aging irrespective 
of the number of calories available to yeast. Because 
these pathways modulate longevity regardless of calorie 
availability, we called them “constitutive” or 
“housekeeping” [1]. LCA modulates these house-
keeping longevity assurance pathways by suppressing 
lipid-induced necrosis, attenuating mitochondrial 
fragmentation, altering oxidation-reduction processes in 
mitochondria, enhancing resistance to oxidative and 
thermal stresses, suppressing mitochondria-controlled 
apoptosis, and enhancing stability of nuclear and 
mitochondrial DNA ([1]; Figure 1C). The housekeeping 
longevity pathways do not overlap with the TOR (target 
of rapamycin) and cAMP/PKA (cAMP/protein kinase 
A) signaling pathways ([1]; Figure 1A), both of which 
are “adaptable”  by nature because  they  are  under  the 
 
 

























stringent control of calorie and/or nutrient availability 
([2-6]; Figure 1B). 
 
  In the other mechanism, LCA targets the adaptable 
cAMP/PKA pathway by unmasking an anti-aging 
potential of PKA under non-CR conditions, perhaps by 
activating PKA-dependent phosphorylation of the 
cytosolic pool of the key nutrient-sensory protein kinase 
Rim15p [1]. The phosphorylation of Rim15p by PKA 
inactivates its protein kinase activity [7]. Hence, the 
LCA-driven inactivation of Rim15p may reduce the 
phosphorylation status of its known [8] target proteins 
in the cytosol, thereby lowering their pro-aging efficacy 
([1]; Figure 1A).         
  
Bile acids are beneficial to health and longevity in 
animals 
 
Although bile acids in mammals have been traditionally 
considered only as trophic factors for the enteric 
epithelium and detergents for the emulsification and 
absorption of dietary lipids [9-11], they are now also 
recognized for their essential role as signaling 
molecules regulating lipid, glucose and energy 
homeostasis and activating detoxification of xenobiotics 
([9-14]; Figure 2A). Many of the numerous health-





















synthesize  bile  acids.  We  therefore  propose  that  bile  acids  released  into  the  environment  by  mammals  may  act  as
interspecies chemical signals providing longevity benefits to yeast and, perhaps, other species within an ecosystem.  
  www.impactaging.com  AGING, August 2010, Vol. 2. No 8
   
www.impactaging.com                   461                                          AGING,    August 2010, Vol.2 No.8their demonstrated ability to protect mammals from 
xenobiotic toxins ([9-14]; Figure 2A) suggest that, by 
improving overall health, these amphipathic molecules 
may delay the onset of age-related diseases and have 
beneficial effect on longevity. Furthermore, because of 
the elevated levels of several bile acids in the long-lived 
Ghrhr
lit/lit mice and due to the ability of cholic acid 
administered to food of wild-type mice to activate 
transcription of numerous xenobiotic detoxification 
genes, it has been proposed that, by promoting chemical 
hormesis in mammals, these mildly toxic molecules 
with detergent-like properties may extend their 
longevity by acting as endobiotic regulators of aging 
[15-18]. Moreover, bile acid-like dafachronic acids 
(including 3-keto-LCA) in worms function as endocrine 
regulators of aging by activating an anti-aging 
transcriptional program governed by the DAF-12/DAF-
16 signaling cascade ([19-21]; Figure 2B). Altogether, 
these findings support the notion that bile acids are 
beneficial to health and longevity in animals because of 
their ability to operate as potent signaling molecules that 
modulate a compendium health- and longevity-related 
processes. Noteworthy, by modulating many of these 
processes also in yeast, LCA extends their longevity [1]. 
It is likely therefore that the life-extending capacity of 
LCA and other bile acids as well as, perhaps, the 
mechanisms underlying their anti-aging action are 
conserved across animal species and other phyla. 
 
Bile acids may function as interspecies chemical 
signals extending yeast longevity within ecosystems 
 
Importantly, yeast do not synthesize LCA or any other 
bile acid found in mammals [1,11,22]. We therefore 
hypothesize that bile acids released into the 
environment by mammals may act as interspecies 
chemical signals providing longevity benefits to yeast. 
In our hypothesis, these mildly toxic compounds 
released into the environment by mammals may create 
selective pressure for the evolution of yeast species that 
can respond to the resulting mild cellular damage by 
developing the most efficient stress protective 
mechanisms. Such mechanisms may provide effective 
protection of yeast not only against cellular damage 
caused by bile acids (and, perhaps, by other 
environmental xenobiotics) but also against molecular 
and cellular damage accumulated with age. In our 
hypothesis, yeast species that have been selected for the 
most effective mechanisms providing protection against 
bile acids (and other environmental xenobiotics) are 
expected to evolve the most effective anti-aging 
mechanisms that are sensitive to regulation by bile acids 
(and, perhaps, by other environmental xenobiotics). 
Thus, the ability of yeast to sense bile acids produced 
by mammals and then to respond by undergoing certain 
life-extending changes to their physiology (Figure 1) is 
expected to increase their chances of survival, thereby 
creating selective force aimed at maintaining such ability. 
   
Natural variations of bile acid levels within 
ecosystems may modulate both housekeeping and 
adaptable longevity pathways in yeast 
 
Noteworthy, the bulk quantity of bile acids in mammals 
exists as an organismal pool which cycles between 
intestine and liver in the enterohepatic circulation due to 
the efficient reabsorption of bile acids in the terminal 
ileum [10,11]. However, about 5% (up to 600 mg/day) 
of this pool escapes each reabsorption cycle, being 
continuously released into the large intestine and 
ultimately into the environment [10,11]. Thus, yeast are 
permanently exposed to bile acids due to their fecal loss 
by mammals. It is conceivable therefore that, in yeast 
exposed to bile acids released by mammals, these 
interspecies chemical signals modulate housekeeping 
longevity assurance pathways that 1) regulate yeast 
longevity irrespective of the state of the environment or 
food supply (i.e., the number of available calories and 
nutrients); and 2) do not overlap (or only partially 
overlap) with the adaptable TOR and cAMP/PKA 
longevity pathways that are under the stringent control 
of calorie and nutrient availability.  
 
  It should be stressed, however, that the quantity of 
bile acids released into the environment by mammals 
could vary due to changes in the density of 
mammalian population and, perhaps, due to other 
environmental factors (including the abundance of 
food available to mammals, its nutrient and caloric 
content, and its fat mass and quality). In fact, the 
organismal pool of bile acids in mammals is under the 
stringent control of regulatory mechanisms operating 
in the liver during the fasting-refeeding transition [9-
11]. Hence, it is likely that, in addition to the ability of 
yeast to respond to the permanently available 
exogenous pool of bile acids by modulating some 
housekeeping longevity assurance pathways, they have 
also evolved the ability to sense the environmental 
status-dependent variations of bile acids abundance by 
modulating the adaptable TOR and cAMP/PKA 
longevity pathways. Importantly, our recent study 
provided evidence for two mechanisms underlying the 
life-extending effect of LCA in yeast; one mechanism 
involves the calorie supply-independent modulation of 
a compendium of housekeeping longevity assurance 
processes that are not regulated by the TOR and 
cAMP/PKA pathways, whereas the other mechanism 
operates only in yeast on a calorie-rich diet by 
unmasking the previously unknown anti-aging poten-
tial of the calorie supply-dependent PKA [1]. 
   
























































































































www.impactaging.com                   463                                          AGING,    August 2010, Vol.2 No.8It remains to be seen if our hypothesis on the essential 
role of bile acids as interspecies chemical signals 
regulating longevity in yeast is applicable to other 
species routinely exposed to bile acids within an 
ecosystem, such as plants and bacteria. 
 
Rapamycin may also act as an interspecies chemical 
signal modulating longevity at the ecosystemic level 
 
Our hypothesis on longevity regulation by bile acids 
within ecosystems may explain the evolutionary origin 
of the life-extending effect of another anti-aging 
compound, called rapamycin. Synthesized by soil 
bacteria to inhibit growth of fungal competitors, this 
macrocyclic lactone provides longevity benefit to yeast, 
fruit flies and mice by specifically inhibiting TOR 
(Tor1p in yeast), a nutrient-sensory protein kinase that 
operates as a master negative regulator of the key 
adaptable longevity pathway [3,4,23-25]. Because 
rapamycin delays proliferative growth of organisms 
across phyla by causing G1 cell cycle arrest [3,4,26], it 
could be considered as a mildly cytotoxic compound, 
akin to bile acids (Our recent unpublished data revealed 
that rapamycin is a more toxic hormetic molecule than 
LCA and other bile acids). We propose therefore that, 
following its release into the environment by soil 
bacteria, rapamycin may create selective pressure for 
the evolution of yeast, fly and mammalian species that 
can respond to rapamycin-induced growth retardation 
by developing certain mechanisms aimed at such 
remodeling of their anabolic and catabolic processes 
that would increase their chances of survival under 
conditions of slow growth. It is plausible that some of 
these mechanisms delay aging by optimizing essential 
longevity-related processes and remain sensitive to 
modulation by rapamycin. Hence, the ability of yeast, 
fruit flies and mice to sense rapamycin produced by soil 
bacteria and then to respond by undergoing certain life-
extending changes to their physiology is expected to 
increase their chances of survival, thereby creating 
selective force for maintaining such ability.  
 
Interestingly, rapamycin has been shown to increase life 
span in fruit flies under dietary restriction conditions 
[25], when the TOR-governed adaptable pro-aging 
pathways are fully suppressed and the TOR-governed 
adaptable anti-aging pathways are fully activated [3,4]. 
It is plausible therefore that - similar to the proposed 
above anti-aging mechanism of LCA in yeast - 
rapamycin in fruit flies can modulate both the 
housekeeping (TOR-independent) and adaptable (TOR-
dependent) longevity pathways. Hence, it is tempting to 
speculate that, in addition to the ability of fruit flies to 
respond to the permanently available exogenous pool of 
rapamycin by modulating some housekeeping longevity 
assurance pathways, they have also evolved the ability 
to sense the environmental status-dependent variations 
of rapamycin abundance (due to, e.g., changes in the 
density of soil bacteria population) by modulating the 
TOR-governed adaptable longevity pathways. Of note, 
recent findings in yeast imply that - in addition to its 
role as a master negative regulator of the key adaptable 
longevity pathway - Tor1p may also operate as a 
positive longevity regulator, in particular by stimulating 
nuclear import of the transcriptional factors Sfp1p, Rtg1 
and Rtg3 in response to partial mitochondrial 
dysfunction or changes in the exogenous and 
endogenous levels of glutamate and glutamine [27-29]. 
The ability of these transcriptional factors to regulate 
metabolism, ribosome biogenesis and growth is crucial 
for longevity [28,30,31]. 
 
The “xenohormesis” hypothesis: a case of 
xenohormetic phytochemicals  
 
Our hypothesis on longevity regulation by bile acids 
and rapamycin within ecosystems complements the 
“xenohormesis” hypothesis, in which plants and other 
autotrophic organisms respond to various environmental 
stresses (i.e., UV light, dehydration, infection, 
predation, cellular damage and nutrient deprivation) by 
synthesizing a compendium of secondary metabolites 
[32-34]. Within plants and other autotrophs producing 
these phytochemicals in response to environmental 
stresses, they activate defense systems protecting the 
host organisms against such stresses. In addition, these 
phytochemicals constitute a chemical signature of the 
environmental status of an ecosystem. As such, they 
provide to heterotrophic organisms (i.e., animals and 
fungi) within the ecosystem an advance warning about 
deteriorating environmental conditions [33]. By 
operating as interspecies chemical signals, they could 
create selective pressure for the evolution of 
heterotrophic organisms that can sense these signals and 
then to respond by altering their metabolism in 
defensive preparation for the imminent adversity while 
conditions are still favorable. The resulting metabolic 
remodeling causes such specific changes in physiology 
of heterotrophs that are beneficial to their health and 
longevity [33]. Although xenohormetic 
phytochemicals are produced by autotrophic organisms 
only in response to hormetic environmental stresses, it 
is unlikely that they function as mildly toxic hormetic 
molecules within heterotrophic organisms; rather, the 
xenohormesis hypothesis proposes that the beneficial 
to health and longevity effects of xenohormetic 
phytochemicals are due to their well known ability to 
modulate the key enzymes of stress-response pathways 
governing numerous longevity-related processes in 
heterotrophic organisms [33-42]. The xenohormetic 
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longevity regulation mechanisms has been proposed to 
be driven by such phytochemicals as resveratrol, 
butein, fisetin and other polyphenols, as well as by 
curcumin [32-34]. The ability of caffeine to increase 

















































activity of Tor1p [43] suggests that this xanthine 
alkaloid could also operate as a xenohormetic 
phytochemical signal providing an advance warning 
about deteriorating environmental conditions to yeast, 










































































































































































compounds  that  1)  are  produced  and  then  released  into  the  environment  permanently  or  only  in  response  to  deteriorating
environmental conditions, increased population density of competitors and/or predators, or changes in food availability and its nutrient







physiology  in  response  to  a  compendium  of  “critical”  chemical  compounds  that  are  permanently  or  transiently  released  to  the
ecosystem by other groups of organisms. Abbreviations: LCA, lithocholic acid; DCA, bile acid‐like dafachronic acids. 
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aging by attenuating the growth-promoting TOR 
signaling pathway 
 
A common feature of many anti-aging compounds - 
some of which are mildly toxic hormetic molecules, 
whereas the others are non-toxic xenohormetic 
phytochemicals - is that they exhibit a cytostatic effect 
by inhibiting TOR, a nutrient-sensing signaling pathway 
that promotes proliferative growth in all heterotrophic 
organisms. A recently proposed “anti-aging side effect” 
hypothesis envisions that the primary objective for the 
synthesis of these cytostatic compounds by a group of 
the organisms composing an ecosystem is to suppress 
growth of other group(s) of organisms within this 
ecosystem, thereby killing competitors and/or protecting 
themselves from predators [39]. Due to its central role 
in promoting proliferative growth of all heterotrophic 
organisms, the TOR signaling pathway is a preferable 
target of such cytostatic compounds [3,26,39,44,45]. 
Because the TOR pathway provides a molecular link 
between growth and aging by driving a so-called quasi-
programmed aging [3,44,45], these compounds exhibit 
a side effect of suppressing aging [39]. In fact, soil 
bacteria synthesize rapamycin to suppress growth of 
fungal competitors by inhibiting the TOR protein 
kinase, a master positive regulator of the TOR signaling 
pathway that drives developmental growth of young 
organisms [3,23-25]. However, since - according to the 
anti-aging side effect hypothesis - in heterotrophic 
organisms across phyla this pathway also drives aging 
after their developmental growth is completed [44,45], 
rapamycin has a side effect of suppressing aging of all 
groups of heterotrophic organisms within an ecosystem 
[39]. Moreover, the anti-aging side effect hypothesis 
predicts that plants synthesize resveratrol in part to 
protect their grapes by inhibiting fungal growth [39]. 
Yet, because this small polyphenol attenuates the TOR 
signaling pathway by modulating key upstream 
regulators and downstream targets of the TOR protein 
kinase [35-42], resveratrol also displays a side effect of 
slowing down quasi-programmed TOR-driven aging of 
various species of heterotrophic organisms within an 
ecosystem [39]. 
 
In the anti-aging side effect hypothesis,  cytostatic 
compounds attenuating the TOR pathway operate as 
interspecies chemical signals that provide longevity 
benefits to a range of heterotrophic organisms 
composing an ecosystem [39]. We propose that, 
following their release into the environment by soil 
bacteria or plants, these growth suppressing chemical 
compounds may create selective pressure for the 
evolution of yeast, worm, fly and mammalian species 
that can respond to the resulting retardation of their 
growth by developing certain mechanisms aimed at 
specific remodeling of the TOR-governed signaling 
network. By targeting the TOR protein kinase itself 
and/or its numerous upstream regulators and 
downstream targets, such mechanisms may attenuate 
the hyper-activation of TOR-governed cellular signaling 
pathways and cellular functions that - according to the 
concept of quasi-programmed TOR-driven aging 
[44,45] - are initiated after developmental growth of a 
heterotrophic organism is completed. In our hypothesis, 
the species of heterotrophic organisms that have been 
selected for the most efficient mechanisms preventing 
the hyper-activation of TOR-governed cellular signaling 
pathways and cellular functions following the 
completion of developmental growth are expected to 
evolve the most effective anti-aging mechanisms. Such 
mechanisms may be sensitive to various environmental 
factors, including the density of organism population 
and abundance of nutrients within an ecosystem.       
 
The xenohormetic, hormetic and cytostatic selective 
forces may drive the evolution of longevity 
regulation mechanisms within ecosystems 
 
Unlike xenohormetic phytochemicals that are non-toxic 
compounds transiently synthesized and released by 
autotrophs only in response to environmental stresses 
[33,34], bile acids are mildly toxic hormetic molecules 
that are permanently synthesized and released by 
mammals [9-11,14-18]. Furthermore, rapamycin is a 
more toxic hormetic molecule than bile acids (our 
unpublished data) that is permanently synthesized and 
released by soil bacteria [46]. Moreover, many 
xenohormetic phytochemicals and mildly toxic 
hormetic molecules exhibit a cytostatic effect by 
attenuating TOR-governed cellular signaling pathways 
and cellular functions [39]. Therefore, by fusing the 
xenohormesis hypothesis [32-34], the anti-aging side 
effect hypothesis [39] and the proposed here hypothesis 
on longevity regulation by bile acids and rapamycin 
within ecosystems, we put forward a unified hypothesis 
of the xenohormetic, hormetic and cytostatic selective 
forces driving the evolution of longevity regulation 
mechanisms at the ecosystemic level.  
 
 In our unified hypothesis (Figure 3), organisms from all 
domains of life (i.e., bacteria, fungi, plants and animals) 
within an ecosystem are able to synthesize chemical 
compounds that 1) are produced and then released into 
the environment permanently or only in response to 
deteriorating environmental conditions, increased 
population density of competitors and/or predators, or 
changes in food availability and its nutrient and/or 
caloric content; 2) are mildly toxic compounds that 
trigger a hormetic response in an organism that senses 
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within the ecosystem and do not cause a hormetic 
response; 3) are cytostatic compounds that attenuate the 
TOR-governed signaling network (e.g., rapamycin and 
resveratrol) or, alternatively, do not modulate this 
growth-promoting network (e.g., LCA and other bile 
acid) and 4) extend longevity of organisms that can 
sense these compounds, thereby increasing their 
chances of survival and creating selective force aimed at 
maintaining the ability of organisms composing the 
ecosystem to respond to these compounds by 
undergoing specific life-extending changes to their 
physiology. Our hypothesis implies that the evolution of 
longevity regulation mechanisms in each group of the 
organisms composing an ecosystem is driven by the 
ability of this group of organisms to undergo specific 
life-extending physiological changes in response to a 
compendium of “critical” chemical compounds that are 
permanently or transiently released to the ecosystem by 
other groups of organisms. 
 
Verification of our hypothesis  
 
As the first step towards testing the validity of our 
hypothesis of the xenohormetic, hormetic and cytostatic 
selective forces driving the evolution of longevity 
regulation mechanisms within ecosystems, we are 
currently carrying out the LCA-driven experimental 
evolution of longevity regulation mechanisms in 
chronologically aging yeast cultured under laboratory 
conditions. If we could select long-lived yeast species 
following a long-term exposure of wild-type yeast to 
LCA, we would be able to begin addressing the 
following intriguing questions: 1) what genes are 
affected by mutations responsible for the extended 
longevity of selected long-lived yeast species? 2) how 
these mutations influence a compendium of the 
housekeeping longevity-related processes modulated by 
LCA in chronologically aging yeast ([1]; Figure 1); 3) 
will these mutations affect the growth rate of yeast in 
media with or without LCA? 4) will selected long-lived 
yeast species be able to maintain their ability to live 
longer than wild-type yeast if they undergo several 
successive passages in medium without LCA? - and, 
thus, is there selective pressure aimed at maintaining of 
an “optimal” rather than a “maximal” chronological life 
span of yeast (due to, e.g., a proposed selective 
advantage of the envisioned “altruistic” program [47-
52] of chronological aging in yeast)? and 5) if mixed 
with an equal number of wild-type yeast cells, will 
selected long-lived yeast species out-grow and/or out-
live them in medium without LCA or the opposite will 
happen (due to selective pressure on yeast aimed at 
maintaining of the so-called “altruistic” program [47-
52] of their chronological aging)? 
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